Nanoviricides (NNVC) Change in Cash (2010 - 2026)
Nanoviricides (NNVC) posted Change in Cash of -$1.9 million for Q1 2026, down 148.13% sequentially from $4.0 million in Q4 2025, and down 36.87% YoY from -$3.1 million in Q1 2025.
Nanoviricides (NNVC) Change in Cash (2010 - 2026) Analysis & Trends
Nanoviricides has reported Change in Cash for 17 years, with the latest figure at -$1.9 million in Q1 2026.
- Quarterly Change in Cash fell 36.87% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $670666.0 (up 193.85% YoY) and the FY2025 annual result came in at -$3.2 million, up 3.37% from the prior year.
- Change in Cash eased to -$1.9 million in Q1 2026 per NNVC's latest filing, from $4.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $4.0 million in Q4 2025 and troughed at -$2.0 million in Q1 2024.
- A 5-year average of -$830743.3 and a median of -$1.4 million in 2025 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 4286.16% in 2025, down 163.88% in 2025.
- Over 5 years, Change in Cash stood at -$1.5 million in 2022, then retreated by 17.33% to -$1.7 million in 2023, then jumped by 105.32% to $91763.0 in 2024, then jumped by 4286.16% to $4.0 million in 2025, then sank by 148.13% to -$1.9 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$1.9 million, $4.0 million, and -$432853.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - | -1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.94 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Sep 30, 2025 | -432,853.00 |
| Jun 30, 2025 | -984,026.00 |
| Mar 31, 2025 | -1.42 Mn |
| Dec 31, 2024 | 91,763.00 |
| Sep 30, 2024 | -931,489.00 |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Dec 31, 2023 | -1.72 Mn |
| Sep 30, 2023 | -1.18 Mn |
| Jun 30, 2023 | -1.50 Mn |
| Mar 31, 2023 | -1.80 Mn |
| Dec 31, 2022 | -1.47 Mn |
| Sep 30, 2022 | -1.15 Mn |
| Jun 30, 2022 | -1.51 Mn |
| Mar 31, 2022 | -1.76 Mn |
| Dec 31, 2021 | -2.36 Mn |
| Sep 30, 2021 | -819,883.00 |
| Jun 30, 2021 | -2.38 Mn |